Mechanical Circulatory Support in Cardiogenic Shock: A Narrative Review

Area of Science:

• Cardiology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Cardiogenic shock (CS) is a life-threatening condition with high mortality, often stemming from acute myocardial infarction or advanced heart failure.
• Traditional medical therapies struggle to manage the severe hemodynamic instability characteristic of CS.
• Mechanical circulatory support (MCS) has become essential for stabilizing patients and bridging them to recovery or advanced therapies.

Purpose of the Study:

• To provide a comprehensive overview of current mechanical circulatory support (MCS) devices used in managing cardiogenic shock (CS).
• To examine the mechanisms, indications, outcomes, and challenges associated with various MCS devices.
• To discuss evolving guidelines and the importance of a multidisciplinary approach in CS management.

Main Methods:

• This narrative review synthesizes current literature on MCS devices for cardiogenic shock.
• It covers devices such as intra-aortic balloon pumps (IABP), veno-arterial extracorporeal membrane oxygenation (VA-ECMO), and percutaneous ventricular assist devices (pVADs).
• The review analyzes their clinical applications, efficacy, and associated complications.

Main Results:

• Various MCS devices, including IABP, VA-ECMO, and pVADs (Impella, TandemHeart), offer different levels of hemodynamic support.
• Each device has specific indications, benefits, and risks that must be carefully considered.
• Successful CS management relies on timely intervention and appropriate device selection.

Conclusions:

• Mechanical circulatory support is a cornerstone in the contemporary management of cardiogenic shock.
• Individualized patient assessment and tailored device selection are critical for optimizing outcomes.
• A multidisciplinary team approach is essential for navigating the complexities of CS and MCS therapy.